News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PuraMed BioScience Invited to Discuss LipiGesic M on Armed Forces Network


8/30/2013 8:20:53 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SCHOFIELD, Wis., Aug. 29, 2013 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCBB:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced that it will discuss LipiGesic M on Armed Forces Network.

Studies show that thirty-seven percent of military veterans who are returning from combat zones suffer with migraine; this ratio is three to four times greater than that of the general population. These veterans with migraine are twice as likely to suffer Post-Traumatic Stress Disorder (PTSD). This creates a hardship for these veterans since the medications that are commonly used to treat PTSD are incompatible with the prescription medications currently used to treat migraine.

"The drug interactions between the PTSD medications and current prescription migraine treatments can be deadly," said Russ Mitchell, CEO of PuraMed BioScience. "We offer these veterans a highly effective alternative to treat their migraines since LipiGesic M has an excellent safety profile and has no reported drug interactions. It is important for veterans suffering both conditions to find treatment, since the symptoms of one will increase the symptoms of the other causing a vicious cycle. With LipiGesic M, veterans are now safe to treat migraine without having to sacrifice their treatment for PTSD."

LipiGesic M is an over-the-counter formulation of feverfew and ginger that has been clinically tested and found to provide rapid-relief from migraine headache and associated symptoms. When clinical trial results of LipiGesic M are compared to those of prescription medications, LipiGesic M is found to be as effective as the top-selling prescription migraine medication, but without the severe effects.

"We are honored that Armed Forces Network requested two interviews with us after they heard our broadcasts on the Big Biz Show," said Mitchell. "We know that LipiGesic M has been well received by the troops and has been battle tested on the frontlines in Afghanistan. It quickly became one of the most requested items in the care packages that were sent to the front. Since it does not cause severe or debilitating side effects, military personnel can take LipiGesic M and get back to the important work of defending our country."

About PuraMed BioScience, Inc.

PuraMed BioScience engages in the research, development, and marketing of non-prescription medicinal and healthcare products. In addition to LipiGesic M, PuraMed BioScience plans to launch LipiGesic H for tension-type headaches and LipiGesic PM, which provides a remedy for insomnia and other sleep disorders. www.puramedbioscience.com

Forward-Looking Statements

This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties that may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact:
Patricia McMurtrie
PuraMed BioScience
1326 Schofield Avenue
Schofield, WI 54476
715-571-4910
patricia@puramedbioscience.com

SOURCE PuraMed BioScience, Inc.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES